As directed by the Physician.Multiple dose vial. Protect from
light. For I.M. use only. Not to be refrigerated.
Dubol is a long acting anabolic preparation containing Nandrolone
Phenypropionate.
Dubol promotes protein anabolism and also provides beneficial
effects in senile osteoporosis. It improves general conditions
in debilitated and convalescing patients and shortens recovery
time. It improves appetite and provides a general sense of being
in convalescent patients. Metabolic studies have shown positive
effects on protein metabolism, nitrogen saving effects and anti
catabolic action. A decrease in urinary calcium has been reported
in cases of increased calceamia.
Nandrolone Phenypropionate is long acting oily preparation which
releases the drug slowly after intramuscular administration. This
leads to prolonged duration of action and infrequent dosage schedule.
Indications:
Tissue building and repair before and after surgery, after severe
injures and burns, after severe infectious diseases, osteoporosis,
acute and chronic renal insufficiency, mammary carcinoma, aplastic
anaemia, refractory anaemia and hemolytic anaemia, general debility,
malnutrition, poor weight gain and in geriatric conditions.
Contradictions: Pregnancy, prostatic carcinoma or mammary carcinoma
in males.
Precautions:
For an optimal therapeutic effect, adequate amount of proteins,
vitamins and minerals should be administered in a calorie rich
diet. Recommended doses should not be exceeded. If signs of virilistation
develop, discontinuation of the treatment should be considered.
Patients with following conditions should be monitored. Latent
or overt cardiac failure, renal dysfunction, hypertension, epilepsy
or migraine, diabetes or latent diabetes, mammary carcinoma and
metastasis.
Dosage: As directed by Physician.
Side effects:
Dubol has a relatively week androgenic effect. Virilisation of
foetus may occur if used during pregnancy. Prolonged treatment
with high doses in prepuberty in children may cause closure of
epiphyses. Unlike 17-alpha Alkyl substituted steroids, is not
associated increases risk of liver damage.
